High doses of aminoglycosides did not produce liver toxicity in patients with cystic fibrosis
- 31 December 1994
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 20 (2) , 201-205
- https://doi.org/10.1016/s0168-8278(05)80058-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Prospective Evaluation of Liver Function Tests in Patients Treated with AminoglycosidesDICP, 1990
- Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosidesThe American Journal of Medicine, 1986
- Fasting Serum Bile Acid Levels in Relation to Liver Histopathology in Cystic FibrosisScandinavian Journal of Gastroenterology, 1985
- Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in ratsKidney International, 1984
- Early effects of gentamicin, tobramycin, and amikacin on the human kidneyKidney International, 1984
- Risk Factors for the Development of Auditory Toxicity in Patients Receiving AminoglycosidesThe Journal of Infectious Diseases, 1983
- Prospective Study of Fatty Acid Supplementation Over 3 Years in Patients with Cystic FibrosisJournal of Pediatric Gastroenterology and Nutrition, 1983
- Hepatobiliary Disease in Cystic FibrosisJournal of Pediatric Gastroenterology and Nutrition, 1982
- ANTIMICROBIAL CHEMOTHERAPY IN CYSTIC FIBROSIS PATIENTSActa Paediatrica, 1982
- The effects of age on alkaline phosphatase and other serologic liver function tests in normal subjects and patients with cystic fibrosisThe Journal of Pediatrics, 1973